In Conversation

ANAM has played, and will continue to play, a central role in supporting the reform processes

Multinational companies will need to present robust dossiers explaining why the government should invest a certain amount of money in their products.

Our pharmaceutical roots and mastery of our craft contribute to the essence of our company

We plan to continue to empower the territories we serve by providing access to better healthcare, safe cities, and sustainable environments

The pragmatic decision making of Morocco’s national leadership gives me cause for economic optimism

[Morocco's] trajectory points towards immense potential and growth

The Moroccan Ministry of Health and its representatives are making a huge effort to improve the regulatory pathway, including pricing and reimbursement aspects. We expect to…

Our differentiating factor is that we are 100 percent focused on generic products and are among the very few Moroccan companies whose products are developed, produced…

Afric-Phar's commitment to supporting rare disease patients is deeply rooted in our guiding philosophy to 'leave no one behind'

We are placing a strong emphasis on innovation, aligning our offerings with the evolving demands of the market

The Minister of Health has clearly defined his objectives in expanding healthcare coverage, renovating the healthcare system, and localizing medical and pharmaceutical supplies in Morocco

The ongoing changes and reforms in [Morocco] are aiming to simplify the investment process and create a more investor-friendly landscape

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here